NCT07006688 2026-04-06A Study of an IDH1m Inhibitor in Participants With IDH1-Mutated Malignancies and Hepatic or Renal ImpairmentServierPhase 1 Recruiting30 enrolled
NCT05756777 2026-03-27A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)Memorial Sloan Kettering Cancer CenterPhase 1 Recruiting18 enrolled